These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24214163)

  • 1. Structure-based design of an RNA-binding p-terphenylene scaffold that inhibits HIV-1 Rev protein function.
    González-Bulnes L; Ibáñez I; Bedoya LM; Beltrán M; Catalán S; Alcamí J; Fustero S; Gallego J
    Angew Chem Int Ed Engl; 2013 Dec; 52(50):13405-9. PubMed ID: 24214163
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of HIV-1 replication by targeting the Rev protein.
    Nakaya T; Iwai S; Fujinaga K; Otsuka E; Ikuta K
    Leukemia; 1997 Apr; 11 Suppl 3():134-7. PubMed ID: 9209321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of benzenesulfonamide quinoline derivatives as potent HIV-1 replication inhibitors targeting Rev protein.
    Zhong F; Geng G; Chen B; Pan T; Li Q; Zhang H; Bai C
    Org Biomol Chem; 2015 Feb; 13(6):1792-9. PubMed ID: 25503645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
    Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
    Eur J Med Chem; 2008 Dec; 43(12):2800-6. PubMed ID: 18242784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of small molecule modulators of HIV-1 Tat and Rev protein accumulation.
    Balachandran A; Wong R; Stoilov P; Pan S; Blencowe B; Cheung P; Harrigan PR; Cochrane A
    Retrovirology; 2017 Jan; 14(1):7. PubMed ID: 28122580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen.
    Prado S; Beltrán M; Coiras M; Bedoya LM; Alcamí J; Gallego J
    Biochem Pharmacol; 2016 May; 107():14-28. PubMed ID: 26896646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.
    Shimane K; Kodama EN; Nakase I; Futaki S; Sakurai Y; Sakagami Y; Li X; Hattori T; Sarafianos SG; Matsuoka M
    Int J Biochem Cell Biol; 2010 Sep; 42(9):1482-8. PubMed ID: 20580677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Rev-export inhibitor from Alpinia galanga and structure-activity relationship.
    Tamura S; Shiomi A; Kaneko M; Ye Y; Yoshida M; Yoshikawa M; Kimura T; Kobayashi M; Murakami N
    Bioorg Med Chem Lett; 2009 May; 19(9):2555-7. PubMed ID: 19342232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
    Luedtke NW; Tor Y
    Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arylazolyl(azinyl)thioacetanilides. Part 10: design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitors.
    Li X; Zhan P; Liu H; Li D; Wang L; Chen X; Liu H; Pannecouque C; Balzarini J; De Clercq E; Liu X
    Bioorg Med Chem; 2012 Sep; 20(18):5527-36. PubMed ID: 22883027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleic acid recognition and antiviral activity of 1,4-substituted terphenyl compounds mimicking all faces of the HIV-1 Rev protein positively-charged α-helix.
    Medina-Trillo C; Sedgwick DM; Herrera L; Beltrán M; Moreno Á; Barrio P; Bedoya LM; Alcamí J; Fustero S; Gallego J
    Sci Rep; 2020 Apr; 10(1):7190. PubMed ID: 32346097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anti-HIV activity of different novel nonclassical nucleosides.
    Elgemeie GE; Mansour OA; Metwally NH
    Nucleosides Nucleotides; 1999 Jan; 18(1):113-23. PubMed ID: 10048227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cell-penetrating antibody fragment against HIV-1 Rev has high antiviral activity: characterization of the paratope.
    Zhuang X; Stahl SJ; Watts NR; DiMattia MA; Steven AC; Wingfield PT
    J Biol Chem; 2014 Jul; 289(29):20222-33. PubMed ID: 24878961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the CRM1-mediated nucleocytoplasmic transport by N-azolylacrylates: structure-activity relationship and mechanism of action.
    Van Neck T; Pannecouque C; Vanstreels E; Stevens M; Dehaen W; Daelemans D
    Bioorg Med Chem; 2008 Nov; 16(21):9487-97. PubMed ID: 18835718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
    Wu B; Kuhen K; Ngoc Nguyen T; Ellis D; Anaclerio B; He X; Yang K; Karanewsky D; Yin H; Wolff K; Bieza K; Caldwell J; He Y
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3430-3. PubMed ID: 16632349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-molecular, non-peptide, non-ATP-competitive polo-like kinase 1 (Plk1) inhibitors with a terphenyl skeleton.
    Mita Y; Noguchi-Yachide T; Ishikawa M; Hashimoto Y
    Bioorg Med Chem; 2013 Feb; 21(3):608-17. PubMed ID: 23276450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
    Sugaya M; Nishino N; Katoh A; Harada K
    J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of caffeoyl-anilides as portmanteau inhibitors of HIV-1 integrase and CCR5.
    Bodiwala HS; Sabde S; Gupta P; Mukherjee R; Kumar R; Garg P; Bhutani KK; Mitra D; Singh IP
    Bioorg Med Chem; 2011 Feb; 19(3):1256-63. PubMed ID: 21227704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenylcoumarin with Rev-export inhibitory activity from Cnidii Monnieris Fructus.
    Tamura S; Fujitani T; Kaneko M; Murakami N
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3717-20. PubMed ID: 20493693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New HIV-1 replication inhibitors of the styryquinoline class bearing aroyl/acyl groups at the C-7 position: synthesis and biological activity.
    Normand-Bayle M; Bénard C; Zouhiri F; Mouscadet JF; Leh H; Thomas CM; Mbemba G; Desmaële D; d'Angelo J
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4019-22. PubMed ID: 16002283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.